Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of CANC's 47 holdings also in XDNA
nan%
% of XDNA's 3 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
 |
ASTRAZENECA PLC | 5.6% |
 |
GILEAD SCIENCES INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 5.0% |
 |
ARGENX SE ADR | 4.6% |
|
BLUEPRINT MEDICINES CORP. | 4.6% |
|
INCYTE CORP | 4.3% |
|
ILLUMINA INC | 4.2% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
EXELIXIS INC | 3.6% |
CANC Underweight Relative to XDNA
|
ARVINAS, INC. | 0.4% |
|
CG ONCOLOGY, INC. | 0.5% |
|
CORBUS PHARMACEUTICALS HOLDINGS INC | 0.5% |
|
JASPER THERAPEUTICS, INC. | 0.5% |
|
RELAY THERAPEUTICS, INC. | 0.6% |
|
JANUX THERAPEUTICS, INC. | 0.7% |
|
IMMUNOCORE HOLDINGS PLC SPONSORED AD | 0.7% |
|
TERNS PHARMACEUTICALS, INC. | 0.7% |
|
CULLINAN ONCOLOGY, INC. | 0.7% |
|
ARCUS BIOSCIENCES, INC. | 0.7% |